Infant Bacterial Therapeutics AB's total assets for Q2 2025 were kr193.23M, a decrease of -7.06% from the previous quarter. SE:IBT.B total liabilities were kr58.88M for the fiscal quarter, a 8.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.